RSLS logo

ReShape Lifesciences (RSLS) Operating Margin

Annual Operating Margin

-168.69%
+72.22%+29.98%

31 December 2023

RSLS Operating Margin Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Operating Margin

-76.83%
+27.70%+26.50%

30 September 2024

RSLS Quarterly Operating Margin Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RSLS Operating Margin Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+30.0%+46.6%
3 y3 years-53.0%+81.0%
5 y5 years+95.8%+34.4%

RSLS Operating Margin High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-53.0%+30.0%at high+81.0%
5 y5 years-60.2%+95.8%-27.4%+81.0%
alltimeall time-60.2%+98.2%-27.4%+99.9%

ReShape Lifesciences Operating Margin History

DateAnnualQuarterly
Sept 2024
-
-76.83%(-26.5%)
June 2024
-
-104.53%(-8.0%)
Mar 2024
-
-113.68%(+18.9%)
Dec 2023
-168.69%(-30.0%)
-95.61%(-33.6%)
Sept 2023
-
-143.99%(-19.0%)
June 2023
-
-177.86%(-27.8%)
Mar 2023
-
-246.22%(+46.4%)
Dec 2022
-240.91%(+20.3%)
-168.23%(-3.4%)
Sept 2022
-
-174.09%(-43.2%)
June 2022
-
-306.47%(-7.8%)
Mar 2022
-
-332.50%(+66.1%)
Dec 2021
-200.24%(+81.6%)
-200.16%(-50.5%)
Sept 2021
-
-404.10%(+285.2%)
June 2021
-
-104.90%(+49.7%)
Mar 2021
-
-70.07%(-29.9%)
Dec 2020
-110.25%(+4.7%)
-99.91%(+65.7%)
Sept 2020
-
-60.30%(-65.8%)
June 2020
-
-176.15%(+20.4%)
Mar 2020
-
-146.32%(+125.5%)
Dec 2019
-105.29%
-64.89%(-44.6%)
DateAnnualQuarterly
Sept 2019
-
-117.16%(+6.5%)
June 2019
-
-110.00%(-20.4%)
Mar 2019
-
-138.13%(-84.9%)
Dec 2018
-4043.00%(-18.0%)
-914.67%(-98.6%)
Sept 2018
-
-66.19 K%(+3.9%)
June 2018
-
-63.73 K%(+911.6%)
Mar 2018
-
-6300.00%(-44.1%)
Dec 2017
-4929.06%(+70.1%)
-11.28 K%(+630.4%)
Sept 2017
-
-1544.27%(-79.1%)
June 2017
-
-7386.93%(-58.0%)
Mar 2017
-
-17.59 K%(+504.3%)
Dec 2016
-2897.77%(-69.6%)
-2910.95%(+93.5%)
Sept 2016
-
-1504.53%(-37.6%)
June 2016
-
-2412.49%(-77.0%)
Mar 2016
-
-10.47 K%(+106.7%)
Dec 2015
-9543.42%(+31.8%)
-5068.04%(-46.0%)
Sept 2015
-
-9391.21%(+1.1%)
June 2015
-
-9292.29%(+270.1%)
Dec 2012
-7239.00%
-
June 2012
-
-2510.48%(-43.7%)
Mar 2012
-
-4457.18%

FAQ

  • What is ReShape Lifesciences annual operating profit margin?
  • What is the all time high annual operating margin for ReShape Lifesciences?
  • What is ReShape Lifesciences annual operating margin year-on-year change?
  • What is ReShape Lifesciences quarterly operating profit margin?
  • What is the all time high quarterly operating margin for ReShape Lifesciences?
  • What is ReShape Lifesciences quarterly operating margin year-on-year change?

What is ReShape Lifesciences annual operating profit margin?

The current annual operating margin of RSLS is -168.69%

What is the all time high annual operating margin for ReShape Lifesciences?

ReShape Lifesciences all-time high annual operating profit margin is -105.29%

What is ReShape Lifesciences annual operating margin year-on-year change?

Over the past year, RSLS annual operating profit margin has changed by +72.22% (+29.98%)

What is ReShape Lifesciences quarterly operating profit margin?

The current quarterly operating margin of RSLS is -76.83%

What is the all time high quarterly operating margin for ReShape Lifesciences?

ReShape Lifesciences all-time high quarterly operating profit margin is -60.30%

What is ReShape Lifesciences quarterly operating margin year-on-year change?

Over the past year, RSLS quarterly operating profit margin has changed by +67.16% (+46.64%)